You have 9 free searches left this month | for more free features.

Hepatitis, Chronic

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)

Not yet recruiting
  • Chronic Hepatitis B
  • PEG IFN α-2b; TAF
  • (no location specified)
Aug 5, 2022

HBV Infection, Chronic Hepatitis b Trial in China (Tenofovir Amibufenamide(TMF))

Recruiting
  • HBV Infection
  • Chronic Hepatitis b
  • Tenofovir Amibufenamide(TMF)
  • Beijing, China
  • +11 more
Mar 22, 2023

Chronic Hepatitis b Trial in Guangzhou (Vitamin D)

Completed
  • Chronic Hepatitis b
  • Vitamin D
  • Guangzhou, Guangdong, China
    Department of Infectious Diseases, The Third Affliated Hospital
Mar 2, 2023

Fibronectin Type ? Domain Containing Protein 5 \ Irsin Gene

Recruiting
  • Hepatitis B, Chronic
  • genotyping
  • Sohag, Egypt
    Sohag university Hospital
Sep 4, 2023

Chronic Hepatitis b Trial in Beijing (ASC22, sodium chloride)

Active, not recruiting
  • Chronic Hepatitis b
  • Beijing, China
    Peking University First Hospital
Jul 18, 2022

Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

Completed
  • Chronic Hepatitis c Genotype 1
  • Moscow, Russian Federation
  • +4 more
Oct 27, 2022

Chronic Hepatitis B Trial (Bepirovirsen, Placebo)

Recruiting
  • Chronic Hepatitis B
  • Herston, Queensland, Australia
  • +7 more
Jan 23, 2023

Hepatocellular Carcinoma, Chronic Hepatitis B Trial in Xiamen (NAs("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") combined

Recruiting
  • Hepatocellular Carcinoma
  • Chronic Hepatitis B
  • NAs("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") combined with interferon treatments
  • NAs ("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") treatments
  • Xiamen, Fujian, China
    Boheng Zhang
Feb 7, 2023

Chronic Hepatitis C Trial in Hines (20mg ezetimibe, Placebo, 40mg ezetimibe)

Terminated
  • Chronic Hepatitis C
  • 20mg ezetimibe
  • +2 more
  • Hines, Illinois
    Edward Hines Jr. VA Hospital, Hines, IL
May 10, 2022

TMF in the Treatment of CHB Patients With Low-level Viraemia

Not yet recruiting
  • Chronic Hepatitis B
  • Chongqing, Chongqing, China
  • +14 more
Mar 3, 2023

Chronic Hepatitis B Virus Infection Trial in Kaohsiung, Taichung, Taipei (Ropeginterferon alfa-2b, Entecavir)

Recruiting
  • Chronic Hepatitis B Virus Infection
  • Kaohsiung, Taiwan
  • +4 more
Aug 12, 2022

Chronic Hepatitis B Trial in Worldwide (Bepirovirsen, Placebo)

Recruiting
  • Chronic Hepatitis B
  • Victoria, British Columbia, Canada
  • +10 more
Jan 23, 2023

Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine

Active, not recruiting
  • Chronic Hepatitis
  • Hepatitis C Infection
  • Electroporation-Mediated Plasmid DNA Vaccine Therapy
  • +4 more
  • Jacksonville, Florida
  • +4 more
Sep 20, 2022

Chronic Hepatitis B, High-Risk Cancer Trial in China (Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue, Nucleos(t)ide

Active, not recruiting
  • Chronic Hepatitis B
  • High-Risk Cancer
  • Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue
  • Nucleos(t)ide analogue
  • Chengdu, China
  • +8 more
Jan 4, 2023

Chronic Hepatitis B, Hepatic Fibrosis, Fatty Liver Trial in Seoul

Active, not recruiting
  • Chronic Hepatitis B
  • +2 more
    • Seoul, Korea, Republic of
      Seoul Metropolitan Government Seoul National University
    May 3, 2022

    Steatohepatitis in Chronic Hepatitis B

    Completed
    • Fatty Liver
    • Chronic Hepatitis b
    • Antiviral Agents
    • Bangkoknoi, Bangkok, Thailand
      Faculty of Medicine Siriraj Hospital
    Mar 30, 2022

    Novel Simplified Score for Chronic Hepatitis B Treatment

    Not yet recruiting
    • Chronic Hepatitis B
    • TREAT-B score
    • Bangkok, Thailand
      Siriraj Hospital
    Apr 1, 2022

    Hepatitis B, Chronic Trial in Jilin (AHB-137 injection, Placebo)

    Recruiting
    • Hepatitis B, Chronic
    • AHB-137 injection
    • Placebo
    • Jilin, China
      The First Hospital of Jilin University
    Nov 2, 2023

    Chronic Hepatitis B Trial run by the NIDDK (hepatitis B immune globulin (HBIg), Pegylated interferon alfa (pegIFN))

    Withdrawn
    • Chronic Hepatitis B
    • hepatitis B immune globulin (HBIg)
    • Pegylated interferon alfa (pegIFN)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 4, 2022

    Hepatitis B Trial in Cambridge (GSK3965193, Placebo to match GSK3965193, Bepirovirsen)

    Recruiting
    • Hepatitis B
    • Cambridge, United Kingdom
      GSK Investigational Site
    Jun 14, 2022

    System of Clinical Endpoint Events for Chronic Hepatitis B

    Active, not recruiting
    • Chronic Hepatitis b
      • Beijing, Beijing, China
      • +6 more
      Sep 2, 2022

      A Study of Chronic Hepatitis C Patients Treated With SOF/VEL/VOX

      Recruiting
      • Hepatitis C
        • Istanbul, Turkey
          Cerrahpasa Medical Faculty
        Aug 26, 2023

        Hepatitis D Trial in Athens (Bulevirtide)

        Recruiting
        • Hepatitis D
        • Athens, Greece
          Department of Gastroenterology, Medical School of National & Kap
        Jun 28, 2023

        Chronic Hepatitis B Trial in Auckland (TAF, TDF, Other approved antivirals)

        Completed
        • Chronic Hepatitis B
        • Auckland, New Zealand
          Auckland City Hospital
        Jun 7, 2022

        HBsAg Declined Patients Follow-up Study

        Not yet recruiting
        • Hepatitis B
        • Hepatitis B, Chronic
          • (no location specified)
          Jul 28, 2023